Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Jan-23 4:11 PM View:  | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 27-Jan-23 | Option Exercise | 1 | $520.01 | $520.01 | < 1% 12.91K to 12.91K | |
| 30-Jan-23 4:11 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 27-Jan-23 | Planned Option Sale | 1 | $747.00 | $747.00 | (< 1%) 12.91K to 12.91K | |
| 10-Jan-23 4:03 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 06-Jan-23 | Planned Option Sale | 3,070 | $747.14 | $2,293,720.00 | (19%) 15.98K to 12.91K | |
| 10-Jan-23 4:03 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 06-Jan-23 | Option Exercise | 3,070 | $520.01 | $1,596,430.00 | 24% 12.91K to 15.98K | |
| 05-Jan-23 4:21 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 15% 1.08K to 1.25K | |
| 05-Jan-23 4:20 PM View: | Poon Christine A Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 9% 1.87K to 2.04K | |
| 05-Jan-23 4:22 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Option Exercise | 1,100 | $372.46 | $409,706.00 | 5% 22.22K to 23.32K | |
| 05-Jan-23 4:37 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | < 1% 19.28K to 19.45K | |
| 05-Jan-23 4:21 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 1% 12.74K to 12.91K | |
| 05-Jan-23 4:16 PM View: | Tessier-Lavigne Marc Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 7% 2.27K to 2.43K | |
| 05-Jan-23 4:15 PM View: | Zoghbi Huda Y Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 15% 1.08K to 1.25K | |
| 05-Jan-23 4:22 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Planned Option Sale | 1,100 | $721.86 | $794,046.00 | (5%) 23.32K to 22.22K | |
| 05-Jan-23 4:15 PM View: | Coles N Anthony Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 15% 1.09K to 1.26K | |
| 05-Jan-23 4:14 PM View: | Thompson Craig B. Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 40 | -- | -- | 14% 0.28K to 0.32K | |
| 05-Jan-23 4:37 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Sale (Planned) | 100 | $726.29 | $72,628.80 | (< 1%) 19.45K to 19.35K | |
| 05-Jan-23 4:16 PM View: | Tessier-Lavigne Marc Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 7% 2.27K to 2.43K | |
| 05-Jan-23 4:19 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | < 1% 28.2K to 28.36K | |
| 05-Jan-23 4:21 PM View: | Goldstein Joseph L Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jan-23 | Grant | 165 | -- | -- | 3% 6.08K to 6.25K | |
| 30-Dec-22 4:10 PM View: | Coles N Anthony Director | Regeneron Pharmaceuticals I... (REGN) | 28-Dec-22 | Option Exercise | 5,758 | $442.24 | $2,546,410.00 | 527% 1.09K to 6.85K | |
| 30-Dec-22 4:10 PM View: | Coles N Anthony Director | Regeneron Pharmaceuticals I... (REGN) | 28-Dec-22 | Planned Option Sale | 5,758 | $714.11 | $4,111,820.00 | (84%) 6.85K to 1.09K | |
| 21-Dec-22 5:45 PM View: | Vagelos P Roy Director | Regeneron Pharmaceuticals I... (REGN) | 20-Dec-22 | Disposition | 141 | $729.53 | $102,864.00 | (< 1%) 479.3K to 479.16K | |
| 20-Dec-22 4:06 PM View: | Fenimore Christopher R. SVP Controller | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 1,926 | -- | -- | 7% 27.73K to 29.66K | |
| 20-Dec-22 4:07 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 2,973 | -- | -- | 15% 19.24K to 22.22K | |
| 20-Dec-22 4:07 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 2,752 | -- | -- | 10% 28.12K to 30.87K | |
| 20-Dec-22 4:08 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 4,129 | -- | -- | 7% 60.91K to 65.04K | |
| 20-Dec-22 4:08 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 1,101 | -- | -- | 2% 62.42K to 63.52K | |
| 20-Dec-22 5:44 PM View: | Vagelos P Roy Director | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 1,651 | -- | -- | < 1% 477.65K to 479.3K | |
| 20-Dec-22 4:09 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 3,798 | -- | -- | 12% 31.15K to 34.95K | |
| 20-Dec-22 4:07 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 16-Dec-22 | Grant | 3,853 | -- | -- | 13% 29.24K to 33.09K | |
| 13-Dec-22 4:13 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 12-Dec-22 | Sale (Planned) | 264 | $730.17 | $192,765.00 | (1%) 19.51K to 19.24K | |
| 13-Dec-22 4:12 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 492 | $753.28 | $370,614.00 | (< 1%) 61.4K to 60.91K | |
| 13-Dec-22 4:11 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 466 | $753.28 | $351,028.00 | (< 1%) 62.88K to 62.42K | |
| 13-Dec-22 4:12 PM View: | Vagelos P Roy Director | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 57 | $753.28 | $42,937.00 | (< 1%) 477.7K to 477.65K | |
| 12-Dec-22 4:34 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 492 | $753.28 | $370,614.00 | (2%) 29.73K to 29.24K | |
| 13-Dec-22 4:09 PM View: | Fenimore Christopher R. SVP Controller | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 247 | $753.28 | $186,060.00 | (< 1%) 27.98K to 27.73K | |
| 13-Dec-22 4:13 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 274 | $753.28 | $206,399.00 | (1%) 19.78K to 19.51K | |
| 13-Dec-22 4:12 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 492 | $753.28 | $370,614.00 | (2%) 28.61K to 28.12K | |
| 13-Dec-22 4:10 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 09-Dec-22 | Payment of Exercise | 492 | $753.28 | $370,614.00 | (2%) 31.64K to 31.15K | |
| 12-Dec-22 4:35 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 08-Dec-22 | Option Exercise | 218 | $380.95 | $83,047.10 | 20% 1.08K to 1.3K | |
| 12-Dec-22 4:34 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 08-Dec-22 | Option Exercise | 3,000 | $381.92 | $1,145,760.00 | 10% 28.99K to 31.99K | |
| 12-Dec-22 4:35 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 08-Dec-22 | Planned Option Sale | 218 | $779.00 | $169,822.00 | (17%) 1.3K to 1.08K | |
| 12-Dec-22 4:34 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 08-Dec-22 | Payment of Exercise | 2,261 | $768.54 | $1,737,670.00 | (7%) 31.99K to 29.73K | |
| 02-Dec-22 4:05 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 02-Dec-22 | Planned Option Sale | 610 | $756.66 | $461,564.00 | (2%) 29.6K to 28.99K | |
| 02-Dec-22 4:05 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 01-Dec-22 | Option Exercise | 2,500 | $381.92 | $954,800.00 | 9% 28.99K to 31.49K | |
| 02-Dec-22 4:07 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Dec-22 | Private Sale (Planned) | 100 | $758.17 | $75,817.50 | (< 1%) 19.38K to 19.28K | |
| 02-Dec-22 4:05 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 01-Dec-22 | Payment of Exercise | 1,890 | $760.35 | $1,437,060.00 | (6%) 31.49K to 29.6K | |
| 02-Dec-22 4:06 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Dec-22 | Option Exercise | 1,100 | $372.46 | $409,706.00 | 6% 19.78K to 20.88K | |
| 02-Dec-22 4:06 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Dec-22 | Planned Option Sale | 1,100 | $756.19 | $831,809.00 | (5%) 20.88K to 19.78K | |
| 25-Nov-22 1:07 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 23-Nov-22 | Option Sale | 11,972 | $740.75 | $8,868,260.00 | (27%) 43.62K to 31.64K | |
| 25-Nov-22 1:07 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 22-Nov-22 | Payment of Exercise | 38,028 | $741.81 | $28,209,600.00 | (47%) 81.64K to 43.62K |
